全文获取类型
收费全文 | 294432篇 |
免费 | 24994篇 |
国内免费 | 11937篇 |
专业分类
耳鼻咽喉 | 3174篇 |
儿科学 | 5135篇 |
妇产科学 | 4188篇 |
基础医学 | 36811篇 |
口腔科学 | 5791篇 |
临床医学 | 33574篇 |
内科学 | 50007篇 |
皮肤病学 | 3841篇 |
神经病学 | 20674篇 |
特种医学 | 12220篇 |
外国民族医学 | 73篇 |
外科学 | 37259篇 |
综合类 | 28601篇 |
现状与发展 | 48篇 |
一般理论 | 193篇 |
预防医学 | 22602篇 |
眼科学 | 7993篇 |
药学 | 26727篇 |
161篇 | |
中国医学 | 9725篇 |
肿瘤学 | 22566篇 |
出版年
2023年 | 2696篇 |
2022年 | 3942篇 |
2021年 | 10439篇 |
2020年 | 7590篇 |
2019年 | 7656篇 |
2018年 | 8588篇 |
2017年 | 7131篇 |
2016年 | 7320篇 |
2015年 | 10438篇 |
2014年 | 13566篇 |
2013年 | 14790篇 |
2012年 | 21677篇 |
2011年 | 23661篇 |
2010年 | 14228篇 |
2009年 | 12224篇 |
2008年 | 17670篇 |
2007年 | 17907篇 |
2006年 | 17367篇 |
2005年 | 17065篇 |
2004年 | 13931篇 |
2003年 | 13340篇 |
2002年 | 12275篇 |
2001年 | 4837篇 |
2000年 | 4443篇 |
1999年 | 4738篇 |
1998年 | 3805篇 |
1997年 | 3329篇 |
1996年 | 2909篇 |
1995年 | 2740篇 |
1994年 | 2331篇 |
1993年 | 1816篇 |
1992年 | 1771篇 |
1991年 | 1696篇 |
1990年 | 1479篇 |
1989年 | 1385篇 |
1988年 | 1242篇 |
1987年 | 1189篇 |
1986年 | 1102篇 |
1985年 | 1095篇 |
1984年 | 1020篇 |
1983年 | 931篇 |
1982年 | 1180篇 |
1981年 | 1198篇 |
1980年 | 992篇 |
1979年 | 636篇 |
1978年 | 658篇 |
1977年 | 573篇 |
1976年 | 504篇 |
1975年 | 456篇 |
1974年 | 458篇 |
排序方式: 共有10000条查询结果,搜索用时 359 毫秒
71.
Richard Kim Elaine Tan Emily Wang Amit Mahipal Dung-Tsa Chen Biwei Cao Fadzai Masawi Cindy Machado James Yu Dae Won Kim 《The oncologist》2020,25(12):e1893-e1899
Lessons Learned
- The combination of trametinib and sorafenib has an acceptable safety profile, albeit at doses lower than approved for monotherapy.
- Maximum tolerated dose is trametinib 1.5 mg daily and sorafenib 200 mg twice daily.
- The limited anticancer activity observed in this unselected patient population does not support further exploration of trametinib plus sorafenib in patients with hepatocellular carcinoma.
72.
目的:观察鼻腔内窥镜下行鼻腔泪囊造孔术治疗慢性泪囊炎的临床疗效。方法回顾性分析2013年6月至2015年6月在我院收治的慢性泪囊炎患者39例(40只眼),采用鼻腔内窥镜下鼻腔泪囊造孔术进行手术治疗,术后随访3~6个月,观察术眼流脓、溢泪等情况。结果鼻内窥镜下鼻腔泪囊造孔术治疗39例(40只眼)患者,治愈35例(36只眼),好转3例(3只眼),无效1例(1只眼)。治愈率90%,好转率7.5%,无效率2.5%。结论经鼻内窥镜下行鼻腔泪囊造孔术治疗慢性泪囊炎,疗效确切。具有手术简单、创伤小、出血少、无需面部切口、面部不留疤痕等优点。 相似文献
73.
74.
75.
Paul J. Devlin Brian W. McCrindle James K. Kirklin Eugene H. Blackstone William M. DeCampli Christopher A. Caldarone Ali Dodge-Khatami Pirooz Eghtesady James M. Meza Peter J. Gruber Kristine J. Guleserian Bahaaladin Alsoufi Linda M. Lambert James E. OBrien Erle H. Austin Jeffrey P. Jacobs Tara Karamlou 《The Journal of thoracic and cardiovascular surgery》2019,157(2):684-695.e8
Objective
Arch obstruction after the Norwood procedure is common and contributes to mortality. We determined the prevalence, associated factors, and practice variability of arch reintervention and assessed whether arch reintervention is associated with mortality.Methods
From 2005 to 2017, 593 neonates in the Congenital Heart Surgeons' Society Critical Left Heart Obstruction cohort underwent a Norwood procedure. Median follow-up was 3.7 years. Multivariable parametric models, including a modulated renewal analysis, were performed.Results
Of the 593 neonates, 146 (25%) underwent 218 reinterventions for arch obstruction after the Norwood procedure: catheter-based (n = 168) or surgical (n = 50) at a median age of 4.3 months (quartile 1-quartile 3, 2.6-5.7). Interdigitation of the distal aortic anastomosis was protective against arch reintervention. Development of ≥ moderate tricuspid valve regurgitation and right ventricular dysfunction at any point was associated with arch reintervention. Nonsignificant variables for arch reintervention included shunt type and preoperative aortic measurements. Surgical arch reintervention was protective against arch reintervention, but transcatheter reintervention was associated with increased reintervention. Arch reintervention was not associated with increased mortality. There was wide institutional variation in incidence of arch reintervention (range, 0-40 reinterventions per 100 years patient follow-up) and in preintervention gradient (range, 0-64 mm Hg).Conclusions
Interdigitation of the distal aortic anastomosis during the Norwood procedure decreased the risk of arch reintervention. Surgical arch reintervention is more definitive than transcatheter. Arch reintervention after the Norwood procedure is not associated with increased mortality. Serial surveillance for arch obstruction, integrated with changes in right ventricular function and tricuspid valve regurgitation, is recommended after the Norwood procedure to improve outcomes. 相似文献76.
目的 探讨剂量组学在预测肺癌根治性放疗患者放射性肺炎发生中的应用潜能。方法 回顾性收集行根治性放疗的314例肺癌患者的临床资料、放疗剂量文件、定位及随访CT图像,根据临床资料及影像学随访资料对放射性肺炎进行分级,提取全肺的剂量组学特征,构建机器学习模型。应用1000次自助抽样法(bootstrap)的最小绝对值收敛和选择算子嵌套逻辑回归(LASSO‐LR)及1000次bootstrap的赤池信息量准则(AIC)向后法筛选与放射性肺炎相关的剂量组学特征,随机按照7∶3划分为训练集及验证集,应用逻辑回归建立预测模型,并应用ROC曲线及校正曲线评价模型的性能。结果 共提取120个剂量组学特征,经LASSO‐LR降维筛选得到12个特征进入“特征池”,再经过AIC向后法筛选,最终筛选出6个剂量组学特征进行模型构建,训练集AUC为0.77(95%CI为0.65~0.87),独立验证集AUC为0.72(95%CI为0.64~0.81)。结论 利用剂量组学建立的预测模型具有预测放射性肺炎发生的潜力,但仍需继续纳入多中心数据及前瞻性数据进一步挖掘剂量组学的应用潜能。 相似文献
77.
78.
79.
The serrated pathway (SP) can be viewed as two parallel, but partially overlapping, arrays of colorectal precursor lesions, and their respective endpoint carcinomas, that are distinct from those of the conventional adenoma–carcinoma sequence (APC‐pathway). In this review we focus at the outset on the clinical impact, pathological features, molecular genetics and biological behaviours of the various SP cancers. Then we summarize the clinicopathological features, classification and molecular profiles of the two main precursor lesions that anchor the respective pathways: (i) sessile serrated adenoma/polyp (SSA/P), also called sessile serrated lesion (SSL), and (ii) traditional serrated adenoma (TSA). Activating mutations of the RAS–RAF–MAPK pathway initiate and sustain the lesions of the SP, and CpG island methylation of the promoter regions of tumour suppressor and DNA repair genes play the major role in their neoplastic progression. The SP includes microsatellite stable (MSS) carcinomas that are among the most biologically aggressive colorectal carcinomas (CRC), and also accounts for the great preponderance of sporadic hypermutated, mismatch repair (MMR)‐deficient or microsatellite instable (MSI) CRC. The identification, removal and appropriate classification of at‐risk SP precursors and surveillance of individuals who harbour these lesions present a challenge and opportunity for CRC prevention and mortality reduction. 相似文献